Comparison of a β-blocker and an if current inhibitor in rabbits with myocardial infarction

Journal of Cardiovascular Surgery

Volumn 47, Issue 6, 2006, Pages 719-725

  Langenbach, M R ^a   Schmitz Spanke, S ^b   Brockert, M ^b   Schepan, M ^b   Pomblum, V J ^b   Gams, E ^b   Zirngibl, H ^a   Schipke, J D ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Adrenegic beta antagonists; Ionic channel; Myocardial infarction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; IVABRADINE; METOPROLOL; MYOSIN ADENOSINE TRIPHOSPHATASE ISOENZYME; MYOSIN ADENOSINE TRIPHOSPHATASE ISOENZYME V1; MYOSIN ADENOSINE TRIPHOSPHATASE ISOENZYME V2; MYOSIN ADENOSINE TRIPHOSPHATASE ISOENZYME V3; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ANALYSIS; HEART DILATATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; HEART RATE; HEART WORK; HUMAN; ISOLATED HEART; MALE; MORTALITY; NONHUMAN; PROTEIN BLOOD LEVEL; Q WAVE; RABBIT; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTA; BENZAZEPINES; BLOOD FLOW VELOCITY; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; HEART RATE; HEART VENTRICLES; MALE; METOPROLOL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; POTASSIUM CHANNEL BLOCKERS; RABBITS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR MYOSINS;

EID: 33846543063     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004;64:1757-65.
2. Borer JS, Fox K, Jaillon P, Lerebours G. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003;107:817-23.
3. Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005;26:2529-36.
4. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
5. Danchin N, Aly S. Heart rate reduction: a potential target for the treatment of myocardial ischaemia. Therapie 2004;59:511-5.
6. Fox K. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina. Expert Opin Pharmacother 2006;7: 1211-20.
7. Vilaine JP. The discovery of selective I(f) current inhibitor ivabradine: A new therapeutic approach to ischemic heart disease. Pharmacol Res 2006;53:424-34.
8. Borer JS. Therapeutic effects of I(f) blockade: Evidence and perspective. Pharmacol Res 2006;53:440-5.
9. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F et al. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004;109:1674-9.
10. ++ sensitization in stunned myocardium. J Mol Cell Cardiol 1997;29:2053-66.
11. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985;72:406-12.
12. Garcia Pomblum SC, Pomblum VJ, Gams E, Reiser FJ, Schipke JD. Electrophoretic separation of ventricular myosin isoenzymes using a native polyacrylamide minigel system. Cell Biochem Biophys 2003;38:33-40.
13. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol 2003;18:215-22.
14. Schipke JD. Cardiac efficiency. Basic Res Cardiol 1994;89:207-40.
15. Collins R. Placebo-controlled trial of early metoprolol in 46.000 acute myocardial infarction patients. ACC, Orlando; 2005.
16. Ruzyllo W, Ford IF, Tendera MT, Fox KF, on behalf of the study investigators. Anti-anginal and anti-ischaemic effects of the if current inhibitor ivabradine compared to amlodipine as monotherapies in patients with chronic stable angina. Randomized, controlled, double-blind trial. Eur Heart J 2004;25(Suppl):138-40.
17. Ragueneau I, Laveille C, Jochemsen R, Resplandy G, Funck-Brentano C, Jaillon P et al. Pharmacokinetic-pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers. Clin Pharmacol Ther 1998;64:192-203.
18. Colin P, Ghaleh B, Monnet X, Su J, Hittinger L, Giudicelli JF et al. Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 2003; 284:H676-H682.
19. Guth BD, Heusch G, Seitelberger R, Ross Jr J. Elimination of exercise-induced regional myocardial dysfunction by a bradycardic agent in dogs with chronic coronary stenosis. Circulation 1987;75:661-9.
20. Monnet X, Colin P, Ghaleh B, Hittinger L, Giudicelli JF, Berdeaux A. Heart rate reduction during exercise-induced myocardial ischaemia and stunning. Eur Heart J 2004;25:579-86.
21. Schmitz-Spanke S, Seyfried E, Schwanke U, Korbmacher B, Sunderdiek U, Winter J et al. [The isolated rabbit heart: comparison between five different modifications]. Herz 2002;27:803-13.
22. Nadaud S, Philippe M, Arnal JF, Michel JB, Soubrier F. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ Res 1996;79:857-63.
23. Varin R, Mulder P, Richard V, Tamion F, Devaux C, Henry JP et al. Exercise improves flow-mediated vasoclilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation 1999;99:2951-7.
24. Kapadia SR. Cytokines and heart failure. Cardiol Rev 1999;7:196-206.
25. Clerico A, Emdin M. Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A Review. Clin Chem 2003;50:33-50.
26. Moazami N, Damiano RJ, Bailey MS, Hess RL, Lawton JS, Moon MR et al. Nesiritide (BNP) in the management of postoperative cardiac patients. Ann Thorac Surg 2003;75:1974-6.
27. Pope B, Hoh JFY, Weeds A. The ATP ase activities of the rat cardiac myosin isoenzymes. FEBS Lett 1980;118:205-8.